Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

H. Shine Chen Schattgen

Associate

Memphis
(901) 543-5924 TEL
(901) 543-5999 FAX

H. Shine Chen Schattgen

Associate

Memphis
(901) 543-5924 TEL
(901) 543-5999 FAX
Memphis
(901) 543-5924 TEL
(901) 543-5999 FAX

Shine Chen Schattgen counsels healthcare clients on a range of operational, regulatory and transactional matters related to clinical trials, physician contracts, healthcare information technology issues, mergers and acquisitions, HIPAA compliance and more. She has experience working with various healthcare institutions, including academic medical centers, hospitals and pharmaceutical and life sciences companies. 

Prior to joining Bass, Berry & Sims, Shine practiced in the Boston office of Ropes & Gray LLP where she advised healthcare clients on compliance issues. Shine earned her law degree from Duke University School of Law and a B.A. in neuroscience and political science from Wellesley College.

Memberships

Memphis Bar Association

American Health Lawyers Association (AHLA)

News

View More

Publications

View More

Media Mentions

View More

Additional Thought Leadership

Publications:

  • "European Union Negotiations Reach Agreement on New Clinical Trials Regulation," Bloomberg BNA Medical Research Law & Policy Report (February 2014)
  • "New EU Clinical Trials Regulation and its Interaction with Proposed EU Privacy Regulation and Proposed EMA Policy on Clinical Trials Data Transparency," Bloomberg BNA Medical Research Law & Policy Report (August 2014)


Accolades

Duke Journal of Constitutional Law and Public Policy – Managing Editor

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.